Annual report pursuant to Section 13 and 15(d)

Note 12 - Related Party Transactions

Note 12 - Related Party Transactions
12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
Related party transactions:
The Company uses Moores Cancer Center at the University of California San Diego (UCSD) to provide pharmacology lab services to the Company. Dr. Stephen Howell is the Acting Chief Medical Officer of Aptose and is also a Professor of Medicine at UCSD and oversees the laboratory work. The work is completed under the terms of research services agreements executed in
March 2015
and has been extended annually. In
March 2019,
the Board approved an extension of this agreement for
months for services up to
These transactions are in the normal course of business and are measured at the amount of consideration established and agreed to by the related parties.
During the year ended
December 31, 2019,
the Company recorded
thousand (
thousand) in research and development expenses related to the agreement.